News for LifeVantage Corporation (LFVN)

LifeVantage Corporation (LFVN) has revealed plans to extend its market presence into Iceland, with the official launch anticipated in September. This strategic

LifeVantage (LFVN) to launch in Iceland in September 2025 with a range of wellness products. The launch includes flagship products and wellness stacks a

LifeVantage (LFVN) reports over 200% increase in natural GLP-1 production from clinical trials. Average weight loss reported at 11 pounds over 12 weeks,

Expanded U.S.-clinical research study shows strong results including increased fat loss, improved cravings control, and healthier body composition*”¡ SALT LA

LifeVantage leads nutrigenomics with strong EPS growth, recurring revenue from MindBody GLP-1, and attractive valuation. Learn why LFVN stock is a buy.

SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® ( LFVN), a leading health and wellness company with products designed to activate

LifeVantage Q3 2025 shows 21% revenue growth, driven by MindBody system success.

LifeVantage Corporation (NASDAQ:LFVN) Q3 2025 Results Conference Call May 6, 2025 4:30 PM ETCompany ParticipantsReed Anderson - Managing Director-ICRSteve...

SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN), a leading health and wellness company with products designed to activate opti

LifeVantage Corporation (LFVN) announces a 12.5% increase in its quarterly dividend. The new dividend amount is $0.045 per share, payable on June 13, 20

**media[616594]**

Discover why LifeVantage (LFVN) is an undervalued growth opportunity with >15% IRR potential, driven by its GLP-1 product launch & business model turnaround.

Shares of ReShape Lifesciences Inc. RSLS rose sharply in today's pre-market trading after the company announced a partnership with Motion Informatics to exclusi...

Following the highly successful launch in U.S. market, LifeVantage begins taking its groundbreaking MB Systemâ„¢ internationally SALT LAKE CITY, March 17, 20

Phase 3 of the Evolve Compensation Plan launches on March 1, 2025, furthering opportunities for success SALT LAKE CITY, March 03, 2025 (GLOBE NEWSWIRE) -- L

**media[556084]**

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company is up over 180 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Earnings Call Insights: LifeVantage Corporation (NASDAQ:LFVN) Q2 2025Management ViewCEO Steve Fife highlighted the success of the MindBody GLP-1 System,...

LifeVantage Corporation (NASDAQ:LFVN) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsReed Anderson – Managing...